| Patient characteristics | Favorable () | Unfavorable () | Total () | value |
| Sex, (%) | | | | 0.244 | Male | 20 (76.9) | 6 (54.5) | 26 (70.3) | | Female | 6 (23.1) | 5 (45.5) | 11 (29.7) | | Age (years), mean (SD) | 60 (11) | 68 (12) | 62 (12) | 0.045 | Pupil reactivity, (%) | | | | 0.642 | None | 1 (3.9) | 2 (18.2) | 3 (8.1) | | One reactive | 5 (19.2) | 1 (9.1) | 6 (16.2) | | Both reactive | 20 (76.9) | 8 (72.7) | 28 (75.7) | | GCS score, median [IQR] | 8.0 [6.0, 11.0] | 7.0 [5.0, 8.0] | 7.0 [6.0, 9.5] | 0.148 | Marshall CT score, median [IQR] | 6.0 [4.0, 6.0] | 4.0 [3.0, 6.0] | 6.0 [3.5, 6.0] | 0.445 | mFisher score, median [IQR] | 3.0 [3.0, 3.0] | 3.0 [2.0, 3.0] | 3.0 [3.0, 3.0] | 0.601 | IVH, (%) | | | | 0.051 | Yes | 5 (19.2) | 6 (54.5) | 11 (29.7) | | No | 21 (80.8) | 5 (45.5) | 26 (70.3) | | Surgery type, (%) | | | | 0.028 | With DC | 20 (76.9) | 4 (36.4) | 24 (64.9) | | Without DC | 6 (23.1) | 7 (63.6) | 13 (35.1) | | EVD days, mean (SD) | 7 (2) | 9 (3) | 7 (2) | 0.097 | ICU days, mean (SD) | 13 (5) | 19 (7) | 15 (6) | 0.004 | CSF output (ml), mean (SD) | 119 (59) | 102 (50) | 114 (56) | 0.424 | Complications, (%) | | | | 0.466 | Yes | 14 (53.8) | 8 (72.7) | 22 (59.5) | | No | 12 (46.2) | 3 (27.3) | 15 (40.5) | |
|
|